Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (23)

2023

  1. Circulating extracellular vesicles promote recovery in a preclinical model of intracerebral hemorrhage

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 247-262

  2. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

  3. Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation

    British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478

  4. Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage

    Frontiers in Cellular Neuroscience, Vol. 16

  5. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors

    Journal of Neurology, Vol. 269, Núm. 11, pp. 5702-5709

  2. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    Multiple Sclerosis and Related Disorders, Vol. 63

2021

  1. Quantifying the patient's perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire

    PLoS ONE, Vol. 16, Núm. 7 July

  2. Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement

    Neurologia, Vol. 36, Núm. 1, pp. 50-60

  3. Spanish expert consensus on the use of safinamide in Parkinson's disease

    Neurologia, Vol. 36, Núm. 9, pp. 666-672

2018

  1. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice

    Stroke, Vol. 49, Núm. 9, pp. 2163-2172

2017

  1. Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain

    Scientific Reports, Vol. 7, Núm. 1

  2. The Direct Referral to Endovascular Center criteria: a proposal for pre-hospital evaluation of acute stroke in the Madrid Stroke Network

    European Journal of Neurology, Vol. 24, Núm. 3, pp. 509-515

2013

  1. Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

    BMC Neurology, Vol. 13

  2. Analysis of the C9orf72 Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide

    Human Mutation, Vol. 34, Núm. 1, pp. 79-82

2010

  1. Management of patients with unclassified epileptic seizures in outpatient clinics in Spain. Results of the RETO study

    International Journal of Neuroscience, Vol. 120, Núm. 11, pp. 711-716

2006

  1. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke

    Neurology, Vol. 67, Núm. 7, pp. 1172-1177

2003

  1. Almotriptan versus rizatriptan in patients with migraine in Spain

    Headache, Vol. 43, Núm. 7, pp. 734-741

2001

  1. Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: A randomized, double-blind, placebo- and active-controlled, multicentre study

    Cephalalgia, Vol. 21, Núm. 5, pp. 604-610

1990

  1. ANGEITIS GRANULOMATOSA DE LA ARTERIA BASILAR EN RELACION CON HERPES ZOSTER DEL VII PAR

    Neurologia, Vol. 5, Núm. 3, pp. 98-101